封面
市場調查報告書
商品編碼
1076355

全球藥物發現人工智能市場-市場規模/份額/趨勢分析:按應用預測(藥物優化和轉移、臨床前研究)、治療領域、地區、細分市場(2022-2030 年)

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

到 2030 年,全球用於藥物發現的人工智能市場規模將達到 91 億美元,預計 2022 年至 2030 年間的複合年增長率為 29.4%。

本報告研究和分析全球人工智能藥物發現市場,並提供市場趨勢、應用/治療領域/地區預測和競爭分析。

目錄

第一章調查方法及範圍

第2章執行摘要

第 3 章全球藥物發現人工智能市場:變量/趨勢/範圍

  • 市場細分
  • 用於藥物發現的人工智能市場動態

第 4 章全球藥物發現人工智能市場:估計和趨勢分析,按應用

  • 用於藥物發現的人工智能市場:應用趨勢分析
  • 藥物優化與分流
  • 臨床前研究
  • 其他用途

第 5 章全球藥物發現人工智能市場:估計和趨勢分析,按治療區域

  • 用於藥物發現的人工智能:治療領域的趨勢分析
  • 腫瘤
  • 神經退行性疾□□病
  • 心血管疾病
  • 代謝性疾病
  • 傳染病
  • 其他

第 6 章全球藥物發現人工智能市場:估計和趨勢分析,按地區

  • 全球人工智能藥物發現市場趨勢分析:按地區劃分
  • 用於藥物發現的全球人工智能市場份額:按地區劃分(2021 年和 2030 年)
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 俄羅斯
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 新加坡
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第7章競爭分□□析

  • 近期趨勢和影響分析:按主要市場進入公司
  • 企業/競爭分類(主要創新者、市場領導者、初創企業)
  • 競爭儀錶盤/企業市場分析
    • 協同效應分析:主要交易和戰略聯盟
    • 主要初創企業/技術顛覆者/創新者名單

第8章競爭態勢

  • IBM Watson
  • Exscientia
  • GNS Healthcare
  • Alphabet(DeepMind)
  • Benevolent AI
  • BioSymetrics
  • Euretos.
  • Berg Health
  • Atomwise
  • Insitro
  • Cyclica
Product Code: GVR-4-68039-029-7

Artificial Intelligence In Drug Discovery Market Growth & Trends:

The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 29.4% from 2022 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.

The drug optimization and repurposing application segment held the largest revenue share in 2021. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2021. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2021. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights:

  • The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 50.0% in 2021
  • By therapeutic area, the oncology segment held the largest revenue share of over 20.0% in 2021. The infectious diseases segment is expected to register the fastest growth rate during the forecast period
  • Asia Pacific is expected to expand at the fastest CAGR of 32.2% from 2022 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery
  • North America led the market and accounted for a revenue share of over 55.0% in 2021. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
    • 1.1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 Segment Share Calculation
  • 1.5 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Artificial Intelligence in Drug Discovery Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
    • 3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis
    • 3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter's Analysis

Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis

  • 4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis
  • 4.2 Drug Optimisation and Repurposing
    • 4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 4.3 Preclinical Testing
    • 4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 4.4 Other Applications
    • 4.4.1 Other Applications Market Estimates And Forecasts, 2016 - 2030 (USD Million)

Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Oncology Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.3 Neurodegenerative Diseases
    • 5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.4 Cardiovascular Disease
    • 5.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.5 Metabolic Diseases
    • 5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.6 Infectious Disease
    • 5.6.1 Infectious Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)

Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis

  • 6.1 Global Artificial Intelligence in Drug Discovery Market Movement Ananlysis, By region
  • 6.2 Global Artificial Intelligence in Drug Discovery Market Share, By region, 2021 & 2030
  • 6.3 North America
    • 6.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.3.2 U.S.
      • 6.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.3.3 Canada
      • 6.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.2 U.K.
      • 6.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.3 Germany
      • 6.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.4 France
      • 6.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.5 Spain
      • 6.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.6 Italy
      • 6.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.4.7 Russia
      • 6.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.2 China
      • 6.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.3 India
      • 6.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.4 Japan
      • 6.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.5 Australia
      • 6.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.6 Singapore
      • 6.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.5.7 South Korea
      • 6.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.6 Latin America
    • 6.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.6.2 Brazil
      • 6.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.6.3 Mexico
      • 6.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.6.4 Argentina
      • 6.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
  • 6.7 MEA
    • 6.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.7.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
    • 6.7.4 UAE
      • 6.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
  • 7.3. Competitive Dashboard & Company Market Position Analysis
    • 7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
    • 7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators

Chapter 8 Competitive Landscape

  • 8.1 IBM Watson
    • 8.1.1 Company Overview
    • 8.1.2 Finanacial Performance
    • 8.1.3 Offerings
    • 8.1.4 Strategic Initiatives
  • 8.2 Exscientia
    • 8.2.1 Company Overview
    • 8.2.2 Finanacial Performance
    • 8.2.3 Offerings
    • 8.2.4 Strategic Initiatives
  • 8.3 GNS Healthcare
    • 8.3.1 Company Overview
    • 8.3.2 Finanacial Performance
    • 8.3.3 Offerings
    • 8.3.4 Strategic Initiatives
  • 8.4 Alphabet (DeepMind)
    • 8.4.1 Company Overview
    • 8.4.2 Finanacial Performance
    • 8.4.3 Offerings
    • 8.4.4 Strategic Initiatives
  • 8.5 Benevolent AI
    • 8.5.1 Company Overview
    • 8.5.2 Finanacial Performance
    • 8.5.3 Offerings
    • 8.5.4 Strategic Initiatives
  • 8.6 BioSymetrics
    • 8.6.1 Company Overview
    • 8.6.2 Finanacial Performance
    • 8.6.3 Offerings
    • 8.6.4 Strategic Initiatives
  • 8.7 Euretos.
    • 8.7.1 Company Overview
    • 8.7.2 Finanacial Performance
    • 8.7.3 Offerings
    • 8.7.4 Strategic Initiatives
  • 8.8 Berg Health
    • 8.8.1 Company Overview
    • 8.8.2 Finanacial Performance
    • 8.8.3 Offerings
    • 8.8.4 Strategic Initiatives
  • 8.9 Atomwise
    • 8.9.1 Company Overview
    • 8.9.2 Finanacial Performance
    • 8.9.3 Offerings
    • 8.9.4 Strategic Initiatives
  • 8.10 Insitro
    • 8.10.1 Company Overview
    • 8.10.2 Finanacial Performance
    • 8.10.3 Offerings
    • 8.10.4 Strategic Initiatives
  • 8.11 Cyclica
    • 8.11.1 Company Overview
    • 8.11.2 Finanacial Performance
    • 8.11.3 Offerings
    • 8.11.4 Strategic Initiatives

List of Tables

  • Table 1 Partial list of secondary sources
  • Table 2 North America Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 3 North America Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 4 U.S. Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 5 U.S. Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 6 Canada Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 7 Canada Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 8 Europe Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 9 Europe Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 10 U.K. Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 11 U.K. Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 12 Germany Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 13 Germany Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 14 France Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 15 France Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 16 Spain Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 17 Spain Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 18 Italy Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 19 Italy Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 20 Russia Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 21 Russia Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 22 Asia Pacific Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 23 Asia Pacific Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 24 China Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 25 China Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 26 India Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 27 India Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 28 Japan Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 29 Japan Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 30 Australia Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 31 Australia Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 32 Singapore Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 33 Singapore Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 34 South Korea Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 35 South Korea Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 36 Latin America Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 37 Latin America Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 38 Brazil Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 39 Brazil Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 40 Mexico Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 41 Mexico Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 42 Argentina Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 43 Argentina Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 44 Middle East & Africa Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 45 Middle East & Africa Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 46 South Africa Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 47 South Africa Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 48 Saudi Arabia Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 49 Saudi Arabia Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)
  • Table 50 UAE Artificial Intelligence drug discovery market, by application, 2016 - 2030 (USD Million)
  • Table 51 UAE Artificial Intelligence drug discovery market, by therapeutic area, 2016 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global Artificial Intelligence in drug discovery market snapshot, 2021 (USD Million)
  • Fig. 9 Global Artificial Intelligence in drug discovery market segmentation
  • Fig. 10 Global Artificial Intelligence in drug discovery market dynamics
  • Fig. 11 Global Artificial Intelligence in drug discovery market driver impact
  • Fig. 12 Global Artificial Intelligence in drug discovery market restraints impact
  • Fig. 13 Global Artificial Intelligence in drug discovery market - PESTLE analysis
  • Fig. 14 Global Artificial Intelligence in drug discovery market - Porter's Analysis
  • Fig. 15 Global Artificial Intelligence in drug discovery market - Application outlook and key takeaways
  • Fig. 16 Global Artificial Intelligence in drug discovery market - Application movement analysis
  • Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 18 Preclinical testing market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 20 Global Artificial Intelligence in drug discovery market - Therapeutic area outlook and key takeaways
  • Fig. 21 Global Artificial Intelligence in drug discovery market - Therapeutic area movement analysis
  • Fig. 22 Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 24 Cardiovascular Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 25 Metabolic Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 26 Infectious Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 28 Global Artificial Intelligence in drug discovery market - Regional outlook and key takeaways
  • Fig. 29 Global Artificial Intelligence in drug discovery market - Regional movement analysis
  • Fig. 30 North America Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 31 U.S. Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 32 Canada Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 33 Europe Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 34 U.K. Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 35 Germany Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 36 France Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 37 Spain Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 38 Italy Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 39 Russia Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 41 China Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 42 India Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 43 Japan Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 44 Australia Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 45 Singapore Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 46 South Korea Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 47 Latin America Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 48 Brazil Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 49 Mexico Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 50 Argentina Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 51 Middle East & Africa Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 52 South Africa Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 54 UAE Artificial Intelligence in drug discovery estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 55 Recent Developments & Impact Analysis, By Key Market Participants
  • Fig. 56 Company market position analysis, 2021
  • Fig. 57 Strategic alliance and deals analysis